Skip to main content
TipRanks
Go Ultimate75% OFF

Cytek Biosciences (CTKB) Revenue

107 Followers

Cytek Biosciences Revenue

Cytek Biosciences had a revenue of 53.23M in the quarter ending Sep 30, 2026, with 10.57%. This bring the company's revenue in the last twelve months to 207.65M, Increased 0.45%. In the fiscal year ending Dec 31, 2025, Cytek Biosciences had annual revenue of 201.49M with 0.52% growth.

Revenue (ttm)
207.65M
Revenue Growth
5.50%
P/S Ratio
3.76
Revenue/Employee
$287,847
Employees
700
Market Cap
$757.24M

Revenue Chart

Cytek Biosciences Revenue - Annual

050M100M150M200M250M57.88M92.84M127.95M164.04M193.01M200.45M201.49M2019202020212022202320242025
Revenue History
Download to Excel
CTKB revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 2025201.49M1.04M0.52%
Dec 31, 2024200.45M7.44M3.85%
Dec 31, 2023193.01M28.98M17.67%
Dec 31, 2022164.04M36.09M28.20%
Dec 31, 2021127.95M35.11M37.82%
Dec 31, 202092.84M34.96M60.39%
Dec 31, 201957.88M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
CTKB207.65M
BIO2.59B
BRKR3.51B
PACB161.39M
QTRX148.15M
QSI1.26M